Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan

International Journal of COPD

Volumn 9, Issue , 2014, Pages 1337-1346

  Yamauchi, Yasuhiro ^a,b   Hasegawa, Wakae ^a   Yasunaga, Hideo ^b   Sunohara, Mitsuhiro ^a   Jo, Taisuke ^a,b   Takami, Kazutaka ^a   Matsui, Hiroki ^b   Fushimi, Kiyohide ^c   Nagase, Takahide ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

COPD; Mortality; Obesity paradox

Indexed keywords

AGED; AGING; ANXIETY; ARTICLE; ASPIRATION PNEUMONIA; ASTHMA; BODY MASS; BODY WEIGHT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONSCIOUSNESS LEVEL; DAILY LIFE ACTIVITY; DATA BASE; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FRACTURE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERSTITIAL PNEUMONIA; ISCHEMIC HEART DISEASE; JAPAN; LIVER DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PNEUMONIA; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; UNDERWEIGHT; AGE; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITAL MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PROTECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PROTECTIVE FACTORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; THINNESS; TIME FACTORS;

EID: 84916942651     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S75175     Document Type: Article

References (47)

1. World Health Organization [webpage on the Internet]. Chronic respi­ratory disease: Burden of COPD. World Health Organization; 2014. Available from: http://www.who.int/respiratory/copd/burden/en/index.html. Accessed September 30, 2014.
2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532.
3. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality fol­lowing acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163(10):1180–1186.
4. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2):81–89.
5. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Out­comes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959–967.
6. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(3):961–966.
7. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861.
8. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
9. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerba­tion of chronic obstructive pulmonary disease. J Gen Intern Med. 2009;24(9):1043–1048.
10. Romero-Corral A, Montori VM, Somers VK, et al. Association of body­weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666–678.
11. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156(1):13–22.
12. Andersen KK, Olsen TS. The obesity paradox in stroke: lower mortal­ity and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. Epub 2013 Mar 12.
13. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007;49(5):581–591.
14. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581–590.
15. Zafrir B, Adir Y, Shehadeh W, Shteinberg M, Salman N, Amir O. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox”. Respir Med. 2013;107(1):139–146.
16. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med. 2006;355(8):779–787.
17. Franssen FM, O’Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117.
18. Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. Epub 2014 Jun 19.
19. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163.
20. Hugh-Jones P, Lambert AV. A simple standard exercise test and its use for measuring exertion dyspnoea. Br Med J. 1952;1(4749):65–71.
21. Ohta T, Waga S, Handa W, Saito I, Takeuchi K. [New grading of level of disordered consiousness (author’s transl)]. No Shinkei Geka. [Neurological surgery]. 1974;2(9):623–627. Japanese.
22. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hem­orrhage by intraventricular infusion of urokinase. J Neurosurg. 1991;74(1):81–86.
23. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65.
24. World Health Organization [webpage on the Internet]. Global Database on Body Mass Index. World Health Organization; 2014. Available from: http://apps.who.int/bmi/index.jsp. Accessed October 26, 2014.
25. Hasegawa W, Yamauchi Y, Yasunaga H, et al. Factors affecting mortal­ity following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med. 2014;14(1):151.
26. Hubbard AE, Ahern J, Fleischer NL, et al. To GEE or not to GEE: com­paring population average and mixed models for estimating the asso­ciations between neighborhood risk factors and health. Epidemiology. 2010;21(4):467–474.
27. Bottai M, Pistelli F, Di Pede F, et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J. 2002;20(3):665–673.
28. Wise RA, Enright PL, Connett JE, et al. Effect of weight gain on pul­monary function after smoking cessation in the Lung Health Study. Am J Respir Crit Care Med. 1998;157(3 Pt 1):866–872.
29. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799.
30. Bolton CE, Evans M, Ionescu AA, et al. Insulin resistance and inflam­mation – A further systemic complication of COPD. COPD. 2007;4(2):121–126.
31. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O’Donnell DE. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med. 2009;180(10):964–971.
32. Guenette JA, Jensen D, O’Donnell DE. Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care. 2010;13(6):618–624.
33. Laviolette L, Sava F, O’Donnell DE, et al. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med. 2010;10:33.
34. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capac­ity ratio predicts mortality in patients with chronic obstructive pulmo­nary disease. Am J Respir Crit Care Med. 2005;171(6):591–597.
35. Watson L, Vonk JM, Löfdahl CG, et al; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Predic­tors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med. 2006;100(4):746–753.
36. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary dis­ease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
37. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519.
38. Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comor­bidity in COPD: systematic literature review. Chest. 2013;144(4):1163–1178.
39. Roversi S, Roversi P, Spadafora G, Rossi R, Fabbri LM. Coronary artery disease concomitant with chronic obstructive pulmonary disease. Eur J Clin Invest. 2014;44(1):93–102.
40. Eriksson B, Lindberg A, Müllerova H, Rönmark E, Lundbäck B. Associ­ation of heart diseases with COPD and restrictive lung function – results from a population survey. Respir Med. 2013;107(1):98–106.
41. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12:26.
42. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–2075.
43. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735.
44. Global Initiative for Asthma [webpage on the Internet]. Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). Global Initia­tive for Asthma; 2014. Available from: http://www.ginasthma.org/documents/14. Accessed July 27, 2014.
45. Hardin M, Silverman EK, Barr RG, et al; COPD Gene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
46. Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87(1):63–74.
47. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58(4):322–327.